Targeted Genetic Changes in Candida albicans Using Transient CRISPR-Cas9 Expression (vol 1, e19, 2021)

被引：0

作者：

Huang, Manning Y. ^{[1
]}

Cravener, Max V. ^{[2
]}

Mitchell, Aaron P. ^{[2
]}

机构：

[1] Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA

[2] Univ Georgia, Dept Microbiol, Athens, Georgia

来源：

CURRENT PROTOCOLS | 2023年 / 3卷 / 03期

关键词：

D O I：

10.1002/cpz1.715

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：2

共 31 条

[21] CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity (vol 42, 113014, 2023)
House, Imran G.
Derrick, Emily B.
Sek, Kevin
Chen, Amanda X. Y.
Li, Jasmine
Lai, Junyun
Todd, Kirsten L.
Munoz, Isabelle
Michie, Jessica
Chan, Cheok Weng
Huang, Yu-Kuan
Chan, Jack D.
Petley, Emma V.
Tong, Junming
Nguyen, Datminh
Engel, Sven
Savas, Peter
Hogg, Simon J.
Vervoort, Stephin J.
Kearney, Conor J.
Burr, Marian L.
Lam, Enid Y. N.
Gilan, Omer
Bedoui, Sammy
Johnstone, Ricky W.
Dawson, Mark A.
Loi, Sherene
Darcy, Phillip K.
Beavis, Paul A.
CELL REPORTS, 2024, 43 (02):
[22] Combining Genome-Wide Gene Expression Analysis (RNA-seq) and a Gene Editing Platform (CRISPR-Cas9) to Uncover the Selectively Pro-oxidant Activity of Aurone Compounds Against Candida albicans
Alqahtani, Fatmah M. M.
Handy, Scott T. T.
Sutton, Caleb L. L.
Farone, Mary B. B.
FRONTIERS IN MICROBIOLOGY, 2021, 12
[23] Inhibition of trans-endothelial migration of HIV-1 infected myeloid cells using virus expression dependent anti-ALCAM CRISPR-Cas9
Kaminski, Rafal
Dabrowski, Konrad
Luongo, Francesca Paola
Myhlyk, Maksym
Ebo, Sunday
Rom, Slava
Young, Won-Bin
Burdo, Tricia
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[24] Normalization of Fmr1RNA and Protein Expression in the Brains of Mice that Model Fragile X Associated Tremor/Ataxia Syndrome (FXTAS) Using CRISPR-Cas9
Yrigollen, Carolyn M.
Ohl, Laura
Lim, Euyn
Zheng, ShuJuan
Brida, Kasey
Chen, Yonghong
Monteys, Alejandro Mas
Davidson, Beverly L.
MOLECULAR THERAPY, 2019, 27 (04) : 419 - 420
[25] Inhibition of HIV-1 replication using the CRISPR/noNLS-Cas9 system as a prophylactic strategy (vol 8, e10483, 2022)
Salimi-Jeda, Ali
Esghaei, Maryam
Keyvani, Hossein
Bokharaei-Salim, Farah
Teimoori, Ali
Abdoli, Asghar
HELIYON, 2023, 9 (02)
[26] Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6 (vol 6, e27873, 2017)
Bak, Rasmus O.
Dever, Daniel P.
Reinisch, Andreas
Hernandez, David Cruz
Majeti, Ravindra
Porteus, Matthew H.
ELIFE, 2018, 7
[27] Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system (vol 12, e0174077, 2017)
Das, Krishna
Eisel, David
Lenkl, Clarissa
Goyal, Ashish
Diederichs, Sven
Dickes, Elke
Osen, Wolfram
Eichmueller, Stefan B.
PLOS ONE, 2018, 13 (12):
[28] CLONING OF HUMAN ABCB11 GENE IN E. COLT FOR INSERTION INTO GENOMIC SAFE HARBOR AAVS1 SITE USING CRISPR-Cas9 REQUIRED THE REMOVAL OF AN INTRAGENIC PRIBNOW-SCHALLER BOX
Vats, Nisha
Girija, Sanal Madhusudana
Sarin, Shiv Kumar
HEPATOLOGY, 2020, 72 : 226A - 226A
[29] Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis (vol 13, pg 1709, 2021)
Teng, Bu-Wei
Zhang, Kun-Dong
Yang, Yu-Han
Guo, Zeng-Ya
Chen, Wei-Wei
Qiu, Zheng-Jun
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (10) : 2085 - 2087
[30] Stable expression of HIV-1 MPER extended epitope on the surface of the recombinant probiotic bacteria Escherichia Coli Nissle 1917 using CRISPR/Cas9 (vol 23, 39, 2024)
Ninyio, Nathaniel
Schmitt, Katharina
Sergon, Gladys
Nilsson, Charlotta
Andersson, Soeren
Scherbak, Nikolai
MICROBIAL CELL FACTORIES, 2024, 23 (01)

← 1 2 3 4 →